Bavarian Nordic is a biotechnology company that develops and manufactures vaccines for infectious diseases and cancer. The company's products are based on its proprietary MVA-BN technology platform, which enables the development of safe and effective vaccines against a wide range of diseases. Bavarian Nordic's lead product is JYNNEOS, a vaccine for smallpox and monkeypox that has been approved by the US FDA and the European Commission. The company also has a pipeline of other vaccine candidates, including vaccines for RSV, HPV, and prostate cancer. Bavarian Nordic was founded in 1994 and is headquartered in Kvistgaard, Denmark.